NASDAQ:NUAN - Nuance Communications Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $53.17
  • Forecasted Upside: 23.24 %
  • Number of Analysts: 8
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 7 Buy Ratings
  • 0 Strong Buy Ratings
$43.14
▼ -1.37 (-3.08%)
1 month | 3 months | 12 months
Get New Nuance Communications Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NUAN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NUAN

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$53.17
▲ +23.24% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Nuance Communications in the last 3 months. The average price target is $53.17, with a high forecast of $65.00 and a low forecast of $21.00. The average price target represents a 23.24% upside from the last price of $43.14.
Buy
The current consensus among 8 investment analysts is to buy stock in Nuance Communications. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/10/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/9/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/8/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/6/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 1 sell ratings
9/4/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 1 sell ratings
12/3/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 1 sell ratings
2/1/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 1 sell ratings
3/3/2021

Latest Recommendations

  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 1 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/9/2021Craig HallumBoost Price TargetBuy$41.00 ➝ $58.00Low
i
2/9/2021SVB LeerinkBoost Price TargetOutperform$54.00 ➝ $55.00Low
i
1/21/2021BarclaysBoost Price TargetOverweight$47.00 ➝ $60.00Low
i
1/19/2021Morgan StanleyBoost Price TargetOverweight$41.00 ➝ $60.00Medium
i
1/13/2021WedbushBoost Price TargetOutperform$45.00 ➝ $65.00Medium
i
12/7/2020SVB LeerinkBoost Price TargetOutperform$42.00 ➝ $47.00Medium
i
Rating by S. Demko at SVB Leerink LLC
11/30/2020GuggenheimUpgradeNeutral ➝ BuyLow
i
11/19/2020SVB LeerinkBoost Price TargetOutperform$38.00 ➝ $42.00High
i
Rating by S. Demko at SVB Leerink LLC
11/19/2020Craig HallumBoost Price TargetIn-Line ➝ Buy$36.00 ➝ $41.00High
i
11/19/2020WedbushBoost Price TargetOutperform$40.00 ➝ $45.00High
i
11/19/2020BarclaysBoost Price TargetOverweight$40.00 ➝ $47.00High
i
11/16/2020Morgan StanleyBoost Price TargetOverweight$33.00 ➝ $35.00Low
i
11/13/2020SVB LeerinkBoost Price TargetOutperform$33.00 ➝ $38.00Medium
i
Rating by S. Demko at SVB Leerink LLC
9/23/2020WedbushBoost Price TargetHold ➝ Outperform$33.00 ➝ $40.00Medium
i
8/11/2020OppenheimerReiterated RatingBuy$21.00Low
i
8/7/2020SVB LeerinkBoost Price TargetOutperform$31.00 ➝ $33.00Medium
i
Rating by S. Demko at SVB Leerink LLC
8/6/2020CfraDowngradeHold ➝ SellLow
i
8/6/2020Craig HallumBoost Price TargetBuy$25.00 ➝ $36.00Low
i
8/6/2020Morgan StanleyBoost Price TargetOverweight$30.00 ➝ $33.00High
i
8/6/2020WedbushBoost Price TargetOutperform$27.00 ➝ $33.00High
i
7/20/2020BarclaysBoost Price TargetOverweight$23.00 ➝ $30.00High
i
7/16/2020Morgan StanleyBoost Price TargetOverweight$20.00 ➝ $30.00Low
i
Rating by Sanjit Singh at Morgan Stanley
6/29/2020SVB LeerinkInitiated CoverageOutperform$31.00Medium
i
Rating by S. Demko at SVB Leerink LLC
4/14/2020GuggenheimInitiated CoverageNeutralHigh
i
3/25/2020Morgan StanleyLower Price TargetOverweight$24.00 ➝ $20.00Low
i
Rating by Sanjit Singh at Morgan Stanley
2/7/2020WedbushReiterated RatingOutperformLow
i
2/3/2020Morgan StanleyReiterated RatingBuy$23.00Medium
i
Rating by Sanjit Singh at Morgan Stanley
1/22/2020BarclaysReiterated RatingBuy$23.00Low
i
1/21/2020WedbushBoost Price TargetOutperform$24.00 ➝ $27.00Low
i
1/13/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$15.00 ➝ $23.00High
i
12/11/2019OppenheimerReiterated RatingBuy$23.00Low
i
Rating by Shaul Eyal at Oppenheimer Holdings Inc.
10/7/2019BarclaysLower Price TargetBuy ➝ Overweight$20.00 ➝ $17.00Low
i
9/27/2019WedbushInitiated CoverageOutperformLow
i
9/23/2019Morgan StanleyLower Price TargetEqual Weight$18.00 ➝ $15.00Low
i
7/24/2019WedbushReiterated RatingBuy$22.00Medium
i
6/23/2019WedbushReiterated RatingBuy$22.00Medium
i
5/9/2019WedbushReiterated RatingBuy$22.00High
i
2/8/2019WedbushReiterated RatingBuy$22.00High
i
1/15/2019Morgan StanleyDowngradeOverweight ➝ Equal Weight$19.00 ➝ $17.00Low
i
10/18/2018WedbushInitiated CoverageOutperform ➝ Outperform$22.00Low
i
8/9/2018Standpoint ResearchDowngradeBuy ➝ HoldHigh
i
8/9/2018BarclaysBoost Price TargetOverweight ➝ Overweight$18.00 ➝ $20.00Low
i
8/9/2018Stifel NicolausBoost Price TargetHold ➝ Hold$15.00 ➝ $17.00High
i
5/10/2018Craig HallumLower Price TargetBuy ➝ In-Line$24.00 ➝ $17.00High
i
5/10/2018Stifel NicolausReiterated RatingHold ➝ Hold$18.00 ➝ $15.00High
i
3/22/2018Morgan StanleySet Price TargetBuy$20.00Medium
i
Rating by Sanjit Singh at Morgan Stanley
1/23/2018OppenheimerReiterated RatingBuy$23.00Low
i
1/22/2018Canaccord GenuityReiterated RatingBuy$21.00High
i
12/18/2017OppenheimerReiterated RatingBuy$23.00Low
i
11/29/2017OppenheimerReiterated RatingBuy$23.00High
i
11/29/2017Stifel NicolausReiterated RatingHold ➝ Hold$19.00 ➝ $18.00High
i
11/22/2017Morgan StanleyReiterated RatingBuy$18.00N/A
i
11/2/2017Morgan StanleyUpgradeEqual Weight ➝ Overweight$18.00N/A
i
8/10/2017OppenheimerReiterated RatingOutperform$26.00 ➝ $23.00High
i
8/9/2017BarclaysLower Price TargetOverweight$22.00 ➝ $21.00Low
i
8/9/2017Raymond JamesLower Price TargetStrong-Buy$24.00 ➝ $22.00Low
i
8/9/2017Deutsche Bank AktiengesellschaftLower Price TargetBuy$25.00 ➝ $23.00Low
i
8/9/2017Canaccord GenuityLower Price TargetBuy$22.00 ➝ $21.00High
i
7/25/2017Morgan StanleyReiterated RatingEqual Weight$19.00 ➝ $18.00Low
i
6/12/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$25.00Medium
i
5/12/2017BarclaysReiterated RatingBuy$22.00Low
i
5/10/2017Stifel NicolausBoost Price TargetHold ➝ Hold$16.00 ➝ $19.00High
i
2/9/2017OppenheimerReiterated RatingOutperform$26.00N/A
i
2/8/2017BarclaysBoost Price TargetOverweight$19.00 ➝ $20.00N/A
i
2/8/2017CitigroupReiterated RatingOutperformN/A
i
2/3/2017Canaccord GenuityReiterated RatingBuy$20.00N/A
i
1/6/2017BarclaysUpgradeEqual Weight ➝ Overweight$17.00 ➝ $19.00N/A
i
Rating by saket kalia at Barclays PLC
11/22/2016UBS GroupReiterated RatingNeutral$15.00 ➝ $16.00N/A
i
11/21/2016OppenheimerReiterated RatingOutperform$26.00N/A
i
11/18/2016Deutsche Bank AktiengesellschaftReiterated RatingBuy$25.00N/A
i
11/18/2016Canaccord GenuityReiterated RatingBuyN/A
i
11/18/2016Raymond JamesUpgradeOutperform ➝ Strong-Buy$24.00N/A
i
11/18/2016UBS GroupUpgradeOutperform ➝ Strong-BuyN/A
i
8/11/2016OppenheimerReiterated RatingOutperform$26.00N/A
i
Rating by Shaul Eyal at Oppenheimer Holdings Inc.
8/9/2016BarclaysSet Price TargetHold$20.00 ➝ $19.00N/A
i
Rating by Saket Kalia at Barclays PLC
8/9/2016Deutsche Bank AktiengesellschaftLower Price TargetBuy$30.00 ➝ $25.00N/A
i
Rating by Sameer Kalucha at Deutsche Bank Aktiengesellschaft
8/9/2016UBS GroupLower Price TargetNeutral$18.00 ➝ $17.00N/A
i
Rating by Brent Thill at UBS Group AG
5/12/2016Needham & Company LLCReiterated RatingHoldN/A
i
Rating by Scott Zeller at Needham & Company LLC
5/12/2016UBS GroupReiterated RatingNeutral$19.00 ➝ $18.00N/A
i
5/11/2016Canaccord GenuityLower Price TargetBuy$22.00 ➝ $20.00N/A
i
Rating by Richard Davis at Canaccord Genuity
5/11/2016SVB LeerinkLower Price TargetOutperform$23.00 ➝ $22.00N/A
i
4/15/2016BarclaysInitiated CoverageEqual Weight$22.00N/A
i
3/24/2016Deutsche Bank AktiengesellschaftReiterated RatingBuyN/A
i
Rating by Benji Star at Deutsche Bank Aktiengesellschaft
3/14/2016Craig HallumBoost Price TargetBuy$26.00N/A
i
3/13/2016OppenheimerReiterated RatingOutperformN/A
i
Rating by Shaul Eyal at Oppenheimer Holdings Inc.
3/12/2016SVB LeerinkReiterated RatingOutperform$21.00 ➝ $23.00N/A
i
(Data available from 3/3/2016 forward)
Nuance Communications logo
Nuance Communications, Inc. provides conversational and cognitive artificial intelligence (AI) innovations that bring intelligence to everyday work and life. The company delivers solutions that understand, analyze, and respond to people - amplifying human intelligence to increase productivity and security. Its Healthcare segment provides clinical speech and clinical language understanding solutions that improve the clinical documentation process, from capturing the complete patient record to improving clinical documentation and quality measures for reimbursement. Its solutions include Dragon Medical One, cloud-based speech solution; computer-assisted physician documentation; diagnostic imaging solutions; Nuance Dragon Ambient eXperience, a voice-enabled solution; and clinical documentation improvement and coding. The company's Enterprise segment primarily engages in using speech, natural language understanding, and artificial intelligence to provide automated customer solutions and services for voice, mobile, Web, and messaging channels. Its solutions include intelligent engagement solutions; Conversational AI; Engagement AI; and Security AI. Its Other segment provides voicemail transcription services. The company serves organizations across healthcare, financial services, telecommunications, government, and retail. Nuance Communications, Inc. markets and sells its solutions and technologies directly through sales force, as well as through a network of resellers, including system integrators, independent software vendors, value-added resellers, distributors, hardware vendors, telecommunications carriers, and e-commerce Websites worldwide. The company was formerly known as ScanSoft, Inc. and changed its name to Nuance Communications, Inc. in October 2005. Nuance Communications, Inc. was founded in 1992 and is headquartered in Burlington, Massachusetts.
Read More

Today's Range

Now: $43.14
$42.58
$44.61

50 Day Range

MA: $47.90
$42.90
$50.51

52 Week Range

Now: $43.14
$13.51
$51.62

Volume

2,463,633 shs

Average Volume

3,337,750 shs

Market Capitalization

$12.30 billion

P/E Ratio

431.40

Dividend Yield

N/A

Beta

1.22

Frequently Asked Questions

What sell-side analysts currently cover shares of Nuance Communications?

The following equities research analysts have issued research reports on Nuance Communications in the last twelve months: Barclays PLC, Cfra, Craig Hallum, Guggenheim, Morgan Stanley, Oppenheimer Holdings Inc., SVB Leerink LLC, Wedbush, and Zacks Investment Research.
View the latest analyst ratings for NUAN.

What is the current price target for Nuance Communications?

6 Wall Street analysts have set twelve-month price targets for Nuance Communications in the last year. Their average twelve-month price target is $53.17, suggesting a possible upside of 19.4%. Wedbush has the highest price target set, predicting NUAN will reach $65.00 in the next twelve months. Oppenheimer Holdings Inc. has the lowest price target set, forecasting a price of $21.00 for Nuance Communications in the next year.
View the latest price targets for NUAN.

What is the current consensus analyst rating for Nuance Communications?

Nuance Communications currently has 1 sell rating and 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe NUAN will outperform the market and that investors should add to their positions of Nuance Communications.
View the latest ratings for NUAN.

What other companies compete with Nuance Communications?

How do I contact Nuance Communications' investor relations team?

Nuance Communications' physical mailing address is 1 WAYSIDE ROAD, BURLINGTON MA, 01803. The software maker's listed phone number is 781-565-5000 and its investor relations email address is [email protected] The official website for Nuance Communications is www.nuance.com.